Effect of omega‐3 and vitamin D co‐supplementation on psychological distress in reproductive‐aged women with pre‐diabetes and hypovitaminosis D: A randomized controlled trial

Related Studies

The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial

Several studies implicate derangements of polyunsaturated fatty acids (FAs) mediated membrane function in the pathophysiology of schizophrenia. Despite preclinical evidence supporting the anti-inflammatory impact of omega-3 FAs on brain health, their biological action as anti-inflammatory agents and their therapeutic impact on the clinical symptoms of psychosis, risk remains poorly understood. In this study by Susai […]

Dose- and time-dependent increase in circulating anti-inflammatory and pro-resolving lipid mediators following eicosapentaenoic acid supplementation in patients with major depressive disorder and chronic inflammation

Supplementing with eicosapentaenoic acid (EPA) is known to be a successful therapy for major depressive disorder (MDD), a condition which is associated with persistent low-grade inflammation. EPA serves as a precursor to specialized pro-resolving lipid mediators (SPMs) known as resolvins (Rv), which play crucial roles in resolving inflammation. In this study by Lamon-Fava et al. […]